SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019713
Filing Date
2023-12-11
Accepted
2023-12-11 16:13:26
Documents
13
Period of Report
2023-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20231209x8k.htm   iXBRL 8-K 38154
  Complete submission text file 0001558370-23-019713.txt   166826

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20231209.xsd EX-101.SCH 4387
3 EX-101.DEF chrs-20231209_def.xml EX-101.DEF 3160
4 EX-101.LAB chrs-20231209_lab.xml EX-101.LAB 16019
5 EX-101.PRE chrs-20231209_pre.xml EX-101.PRE 11312
7 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20231209x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 231478267
SIC: 2836 Biological Products, (No Diagnostic Substances)